We don't hear much directly about or from Dr. Jacob Lalezari, which is unfortunate, because I believe he is a highly regarded research oriented Clinician and obviously a significant contributor to Cytodyn's progress. Dr. Lalezari's creditability, validated by his many years of contributions to clinical research, serves Cytodyn well with the FDA. We are fortunate to have Dr. Lalezari as Interim Chief Medical Officer and expect we will be learning more about his role in the near future. Drs. Lalezari and Patterson make quite a fantastic medical team for a small company. Nader deserves a lot of credit for recognizing and engaging their services. As a very long time shareholder, I am incredibly proud of the Cytodyn team, including those working like crazy behind the scene to advance Leronlimab to where it can do the most good.